Regulatory watch: Characterizing the US FDA's approach to promoting transformative innovation

Nicholas S. Downing; Harlan M. Krumholz; Joseph S. Ross; Nilay D Shah

doi:10.1038/nrd4734

Regulatory watch: Characterizing the US FDA's approach to promoting transformative innovation

Nicholas S. Downing, Harlan M. Krumholz, Joseph S. Ross, Nilay D Shah

Health Sciences Research

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	740-741
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	14
Issue number	11
DOIs	https://doi.org/10.1038/nrd4734
State	Published - Nov 1 2015

ASJC Scopus subject areas

Drug Discovery
Pharmacology

Access to Document

10.1038/nrd4734

Cite this

@article{79b801f56871466d9e584b8579293a39,

title = "Regulatory watch: Characterizing the US FDA's approach to promoting transformative innovation",

author = "Downing, {Nicholas S.} and Krumholz, {Harlan M.} and Ross, {Joseph S.} and Shah, {Nilay D}",

year = "2015",

month = nov,

day = "1",

doi = "10.1038/nrd4734",

language = "English (US)",

volume = "14",

pages = "740--741",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - Regulatory watch

T2 - Characterizing the US FDA's approach to promoting transformative innovation

AU - Downing, Nicholas S.

AU - Krumholz, Harlan M.

AU - Ross, Joseph S.

AU - Shah, Nilay D

PY - 2015/11/1

Y1 - 2015/11/1

UR - http://www.scopus.com/inward/record.url?scp=84946481587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946481587&partnerID=8YFLogxK

U2 - 10.1038/nrd4734

DO - 10.1038/nrd4734

M3 - Article

C2 - 26435528

AN - SCOPUS:84946481587

VL - 14

SP - 740

EP - 741

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 11

ER -